Soyeom-Jetong mixture attenuates NLRP3 inflammasome-mediated inflammation
Frontiers in Pharmacology · 16.06.2026 · 17
DOI: 10.3389/fphar.2026.1836840 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 16.06.2026. Verfasst von Qianying Ye und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science and Technology, Kyung Hee University, Seoul, Republic of Korea. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Soyeom-Jetong (SJ) is a traditional East Asian polyherbal formulation composed of Paeonia lactiflora Pallas, Glycyrrhiza inflata Batal, and Corydalis yanhusuo W.T. Wang, traditionally used for treating inflammatory disorders. Given the central role of the NLRP3 inflammasome in inflammation-related pathologies, SJ is of particular interest as a potential anti-inflammatory modulator. However, the molecular mechanisms underlying the anti-inflammatory effects remain unclear. This study aimed to evaluate the anti-inflammatory efficacy of SJ in a lipopolysaccharide (LPS)-induced zebrafish model and determine its regulatory effects on the NLRP3 inflammasome in vitro .
Methods
Inflammation was induced in zebrafish embryos via LPS exposure and tail amputation. The anti-inflammatory effects of SJ were assessed through Sudan Black B staining and whole-mount in situ hybridization to detect neutrophil infiltration. In vitro assays were performed to investigate the regulatory effects of SJ on NLRP3 inflammasome activation.
Results
SJ significantly reduced neutrophil accumulation in the caudal hematopoietic tissue of LPS-exposed zebrafish and the injury site of zebrafish embryos with amputated tails. It also modulated inflammatory gene expression, including NLRP3 and proinflammatory cytokines. In vitro, SJ suppressed NLRP3 inflammasome activation.
Conclusion
SJ exhibits anti-inflammatory activity by modulating neutrophil inflammation and suppressing NLRP3 inflammasome activation in vitro . These findings provide experimental support for the pharmacological activity of SJ and suggest its potential as an anti-inflammatory candidate for further investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Science and Technology, Kyung Hee University, Seoul, Republic of Korea.
- Department of Microbiology, Ajou University School of Medicine, Suwon, Republic of Korea.
- Department of Biomedical Sciences, Graduate School of Ajou University, Suwon, Republic of Korea.
- BK21 R&E Initiative for Advanced Precision Medicine, Ajou University School of Medicine, Suwon, Republic of Korea.
- Department of Acupuncture and Moxibustion, Joint and Spine Center, Kyung Hee University College of Korean Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea.
- Department of Orthopaedic Surgery, Shoulder and Elbow Clinic, Kyung Hee University School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea.
Zitieren
APA
Ye, Q., Lee, S., Park, Y. C., Kim, M. S., Kim, W., Jin, J. S., Kim, D. K., Jang, S., Lee, S., Lee, N., Lee, S., Seo, B. K., Kim, M. S., Kim, Y., An, D., Seo, S., Lee, D., Kim, H., Park, Y. H., …, & Baek, Y. H. (2026). Soyeom-Jetong mixture attenuates NLRP3 inflammasome-mediated inflammation. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1836840
Vancouver
Ye Q, Lee S, Park YC, Kim MS, Kim W, Jin JS, et al. Soyeom-Jetong mixture attenuates NLRP3 inflammasome-mediated inflammation. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1836840
BibTeX
@article{Ye2026,
author = {Ye, Qianying and Lee, Sojung and Park, Yeon-Cheol and Kim, Myung-Seo and Kim, Wonnam and Jin, Jong-Sik and Kim, Dong-Keun and Jang, Seoyeon and Lee, Sumin and Lee, Nahyun and Lee, Seongjong and Seo, Byung-Kwan and Kim, Man S and Kim, Yeonhak and An, Duckgun and Seo, Sangsu and Lee, Donggyu and Kim, Hyungyu and Park, Yong Hwan and Lee, Yoonsung and Baek, Yong-Hyeon},
title = {Soyeom-Jetong mixture attenuates NLRP3 inflammasome-mediated inflammation},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1836840}
}
EUVIMED